DOT Compliance News
4 articles
growth-positive
AI that speeds up decision making in biomed
Dot Compliance, a company that develops AI-based solutions for quality management systems at life sciences companies, has raised $50 million in venture capital funding. The company, which has about 350 customers, is a pioneer in its category but has a small market share in the $6 billion QMS software market for life sciences companies. The main investors in Dot Compliance are Israel Growth Partners, Vertex Ventures and TPY Capital. The companys product, which is built on a Salesforce platform, is designed to streamline control and save time, which can be worth hundreds of millions of dollars for a pharmaceutical company.
CustomersInvestment
growth-positive
Dot Compliance Raises $17.5M in Series B Extension Funding
Dot Compliance, an AI-enabled quality management system (QMS) solutions provider, has raised $17.5M in a Series B funding round. The round was led by IGP Capital and Vertex Ventures, with participation from TPY Capital, bringing the total amount raised to $50M. The company plans to use the funds to accelerate its AI software solutions, drive product innovation and customer acquisition, and meet the escalating market demand for AI-driven solutions that help life sciences organizations improve quality management and dynamic compliance requirements.
InvestmentCustomers
growth-positive
Dot Compliance Launches First AI Based ChatGPT Powered eQMS for Life Sciences
Dot Compliance has introduced an AI-Based electronic Quality Management System for the life sciences sector. The system utilizes AI algorithms to optimize quality processes and automate tasks, improving compliance and reducing costs. The use of AI in quality management can enhance productivity and speed, making the process more efficient. Dot Compliance is the first company to introduce generative AI to the quality and compliance space. The companys suite of solutions includes pre-validated eQMS processes that can be quickly deployed. The AI platform constantly learns and provides accurate insights and predictions, improving overall efficiency and minimizing risks. Dot Compliances cost-effective and AI-powered solution helps the life science industry reach millions of patients.
CustomersInvestment
growth-positive
Dot Compliance raises $23 million Series B for life science quality and compliance platform CTech
Dot Compliance, an Israeli startup that provides quality and compliance solutions for life-sciences organizations, has raised $23 million in Series B funding. The funding round was led by Israel Growth Partners (IGP) with participation from existing investors Vertex Ventures and TPY Capital. Dot Compliances ready-to-use quality and compliance platform allows life sciences customers to quickly deploy flexible and scalable solutions. The funding will enable the company to continue its hypergrowth driven by the demand for its quality management system (QMS). Dot Compliance has experienced triple-digit annual growth, has over 200 customers in 15 countries, and has established a global network of partners.
Investment
